Back to Stakeholders

The Brain & Behavior Research Foundation (formerly NARSAD) is the world's largest private funder of psychiatric research, having awarded over $475 million to more than 5,000 scientists—including grants specifically supporting psilocybin-assisted therapy trials, ketamine research, and other innovative treatments for depression, PTSD, and schizophrenia. In 2023 alone, the foundation funded seven grants advancing psilocybin-based research and has supported over 90 ketamine-related projects, making it a cornerstone funder of emerging psychedelic science.

Foundations & Philanthropy Snapshot

Psychedelic-Specific Foundations

Classification

Private Foundation

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research FundingClinical Trial Funding

Support Types

Grant Funding

Philanthropy Notes

Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Verified against official BBRF grant program pages.

Primary Funding Link

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

3